咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Development of software for ca... 收藏

Development of software for calculating the results of medicinal substances bioequivalence

作     者:N V Shalaginova E A Mikhlyakova D N Gribkov A V Mikhailina E V Lebedeva 

作者机构:Department of Applied Mathematics and Computer Science Vyatka State University Kirov Russia Secondary school with in-depth study of individual subjects of Stulovo Kirov Russia Graduate student of Vyatka State University Kirov Russia Head of the Department of Informatics and Records Management Orel State Institute of Culture Orel Russia Head of Department of Economics and Management Orel State Institute of Culture Orel Russia Department of Algebra and Mathematical Methods in Economy of Orel State University named after I.S. Turgenev Orel Russia 

出 版 物:《Journal of Physics: Conference Series》 

年 卷 期:2021年第1889卷第5期

学科分类:07[理学] 0702[理学-物理学] 

摘      要:International organizations have adopted and recognized drug standards, which should be guided by developers in the field of pharmacology. In practice, there is a problem: how to determine whether a reproduced drug sample really satisfies the world standard for its pharmacological action. It is required to implement an algorithm for checking and confirming the bioequivalence of drugs. The purpose of the study is to automate the verification of standards using an appropriate algorithm, i.e. to develop an application for calculating the results of medicinal substances bioequivalence. The methodology is based on the assumption that the identity in the sense of the created effect of the pharmacokinetic curves of the drug concentration in the blood versus time for the test drug and the standard means their therapeutic equivalence. Research methods include Python programming, use of libraries for data visualization; Visual Studio is an application development environment. The desired algorithm and requirements for the developed application are formulated in the results of the study, based on the study of theoretical issues of determining the medicinal substances bioequivalence. Finally, conclusions about the efficiency of the software are made and options for its improvement are proposed.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分